Canada - English - Health Canada

teva canada limited - cephalexin (cephalexin monohydrate) - capsule - 250mg - cephalexin (cephalexin monohydrate) 250mg - first generation cephalosporins

Canada - English - Health Canada

teva canada limited - cephalexin (cephalexin monohydrate) - capsule - 500mg - cephalexin (cephalexin monohydrate) 500mg - first generation cephalosporins

Canada - English - Health Canada

teva canada limited - cephalexin (cephalexin monohydrate) - powder for suspension - 250mg - cephalexin (cephalexin monohydrate) 250mg - first generation cephalosporins

Canada - English - Health Canada

teva canada limited - cephalexin (cephalexin monohydrate) - powder for suspension - 125mg - cephalexin (cephalexin monohydrate) 125mg - first generation cephalosporins

Canada - English - Health Canada

teva canada limited - cephalexin (cephalexin monohydrate) - tablet - 250mg - cephalexin (cephalexin monohydrate) 250mg - first generation cephalosporins

Canada - English - Health Canada

teva canada limited - cephalexin (cephalexin monohydrate) - tablet - 500mg - cephalexin (cephalexin monohydrate) 500mg - first generation cephalosporins

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - cefalexin monohydrate, quantity: 550 mg (equivalent: cefalexin, qty 500 mg) - capsule, hard - excipient ingredients: iron oxide yellow; gelatin; sunset yellow fcf; titanium dioxide; magnesium stearate; lactose monohydrate; brilliant blue fcf; purified water; propylene glycol; butan-1-ol; isopropyl alcohol; ethanol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - treatment of the following bacterial infections when caused by susceptible strains of the designated micro-organisms. respiratory tract infections; strep. pneumoniae and group a b-haemolytic streptococci. although penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections (including the prophylaxis of rheumatic fever), cephalexin is generally effective in the eradication of streptococci from the nasopharynx. substantial data establishing the efficacy of cephalexin in the subsequent prevention of rheumatic fever are not available at present. bacterial sinusitis: streptococci, strep. pneumoniae and staph. aureus (methicillin sensitive only). otitis media: strep. pneumoniae, staphylococci (methicillin sensitive only). skin and skin structure infections: staphylococci (methicillin sensitive only) and/or streptococci. genitourinary tract infections, including acute prostatitis: e.coli, p.mirabilis, and klebsiella sp. the effectiveness of cephalexin in the treatment of bacter

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - cefalexin -

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - cefalexin, quantity: 500 mg - capsule - excipient ingredients: gelatin; titanium dioxide; patent blue v; sodium lauryl sulfate; magnesium stearate; microcrystalline cellulose; sunset yellow fcf; quinoline yellow; purified water; propylene glycol; butan-1-ol; isopropyl alcohol; ethanol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; ethanol absolute - respiratory tract infections caused by s. pneumoniae and group a beta-haemolytic streptococci (penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cephalexin generichealth capsules are generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cephalexin capsules in the subsequent prevention of rheumatic fever are not available at present). bacterial sinusitis caused by streptococci, s. pneumoniae and s. aureus (methicillin sensitive only). otitis media. due to s. pneumoniae, staphylococci. skin and soft tissue infections caused by staphylococci and/or streptococci. genitourinary tract infections, including acute prostatitis caused by e. coli, p. mirabilis and klebsiella sp. the effectiveness of cephalexin generichealth capsules in the treatment of bacterial infections of the brain and spinal column has not been established and cephalexin generi

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - cefalexin monohydrate, quantity: 52.576 mg/ml (equivalent: cefalexin, qty 50 mg/ml) - suspension, powder for - excipient ingredients: sodium benzoate; simethicone; iron oxide yellow; citric acid; sucrose; saccharin sodium; guar galactomannan; flavour - treatment of the following infections when caused by susceptible strains of the designated microorganisms. respiratory tract infections. caused by s. pneumoniae and group a beta-haemolytic streptococci (penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cephalexin is generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cephalexin in the subsequent prevention of rheumatic fever are not available at present). bacterial sinusitis. caused by streptococci, s. pneumoniae and s. aureus (methicillin sensitive only). otitis media. due to s. pneumoniae, staphylococci. skin and skin structure infections. caused by staphylococci and/or streptococci. genitourinary tract infections, including acute prostatitis. caused by e. coli, p. mirabilis, and klebsiella sp. the effectiveness of cephalexin in the treatment of bacterial infections of the brain and s